214 related articles for article (PubMed ID: 11340681)
21. Seasonal differences of peak expiratory flow rate variability and mediators of allergic inflammation in non-atopic adolescents.
Ferdousi HA; Munir AK; Zetterström O; Dreborg SK
Pediatr Allergy Immunol; 2001 Oct; 12(5):238-46. PubMed ID: 11737670
[TBL] [Abstract][Full Text] [Related]
22. Major basic protein, but not eosinophil cationic protein or eosinophil protein X, is related to atopy in cystic fibrosis.
Koller DY; Halmerbauer G; Müller J; Frischer T; Schierl M
Allergy; 1999 Oct; 54(10):1094-9. PubMed ID: 10536888
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of eosinophil cationic protein and eosinophils in asthmatic children during a course of prednisolone therapy.
Tang RB; Chen SJ
Pediatr Pulmonol; 2001 Feb; 31(2):121-5. PubMed ID: 11180687
[TBL] [Abstract][Full Text] [Related]
24. Urinary eosinophil protein X in children: the relationship to asthma and atopy and normal values.
Tauber E; Halmerbauer G; Frischer T; Gartner C; Horak F; Veiter A; Koller DY; Studnicka M
Allergy; 2000 Jul; 55(7):647-52. PubMed ID: 10921464
[TBL] [Abstract][Full Text] [Related]
25. Eosinophils, eosinophil cationic protein and eosinophil-derived neurotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis.
Tischendorf FW; Brattig NW; Burchard GD; Kubica T; Kreuzpaintner G; Lintzel M
Acta Trop; 1999 Mar; 72(2):157-73. PubMed ID: 10206116
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness.
Chivato T; Martínez D; Blasco R; Melgarejo M; Gómez de Terreros FJ; Laguna R
Allergol Immunopathol (Madr); 1996; 24(6):243-7. PubMed ID: 9010559
[TBL] [Abstract][Full Text] [Related]
27. [A fundamental study on clinical significance of measuring eosinophil protein X in spot urine in asthmatics].
Oosaki R; Mizushima Y; Kawasaki A; Fujishita T; Kawagishi Y; Mita H; Akiyama K; Kobayashi M
Arerugi; 1998 Dec; 47(12):1273-9. PubMed ID: 10028722
[TBL] [Abstract][Full Text] [Related]
28. Ratio of eosinophil cationic protein/eosinophil count as a new marker in children with acute asthma.
Imai C; Yamazaki H; Tanaka Y; Matsunaga M; Numata O; Torigoe K
Pediatr Int; 1999 Apr; 41(2):142-6. PubMed ID: 10221016
[TBL] [Abstract][Full Text] [Related]
29. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.
Griffin E; Håkansson L; Formgren H; Jörgensen K; Peterson C; Venge P
J Allergy Clin Immunol; 1991 Feb; 87(2):548-57. PubMed ID: 1847158
[TBL] [Abstract][Full Text] [Related]
30. Individual time-courses of ECP and EPX during allergen provocation tests in asthmatic children.
Kleinau I; Niggemann B; Wahn U
Pediatr Allergy Immunol; 1995 May; 6(2):109-18. PubMed ID: 7581720
[TBL] [Abstract][Full Text] [Related]
31. Urinary eosinophil protein X in relation to disease activity in childhood asthma.
Lugosi E; Halmerbauer G; Frischer T; Koller DY
Allergy; 1997 May; 52(5):584-8. PubMed ID: 9201373
[TBL] [Abstract][Full Text] [Related]
32. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
33. High levels of urinary eosinophil protein X in young asthmatic children predict persistent atopic asthma.
Øymar K
Pediatr Allergy Immunol; 2001 Dec; 12(6):312-7. PubMed ID: 11846868
[TBL] [Abstract][Full Text] [Related]
34. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children.
Piacentini GL; Bodini A; Costella S; Vicentini L; Mazzi P; Sperandio S; Boner AL
Eur Respir J; 1999 Jun; 13(6):1386-90. PubMed ID: 10445616
[TBL] [Abstract][Full Text] [Related]
35. Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis.
Koller DY; Nilsson M; Enander I; Venge P; Eichler I
Clin Exp Allergy; 1998 Feb; 28(2):241-8. PubMed ID: 9515599
[TBL] [Abstract][Full Text] [Related]
36. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
37. Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX).
Reimert CM; Ouma JH; Mwanje MT; Magak P; Poulsen LK; Vennervald BJ; Christensen NO; Kharazmi A; Bendtzen K
Acta Trop; 1993 Jun; 54(1):1-12. PubMed ID: 8103623
[TBL] [Abstract][Full Text] [Related]
38. Manifold significance of serum eosinophil cationic protein in asthmatic children.
Zubović I; Rozmanić V; Ahel V; Banac S
Acta Med Croatica; 2002; 56(2):53-6. PubMed ID: 12596625
[TBL] [Abstract][Full Text] [Related]
39. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity.
Frederick JM; Warner JO; Jessop WJ; Enander I; Warner JA
Eur Respir J; 1997 Feb; 10(2):361-6. PubMed ID: 9042633
[TBL] [Abstract][Full Text] [Related]
40. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]